Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models

Bibliography

• Spitsbergen JM, Kent ML. The state of the art of the zebrafish model for toxicology and toxicologic pathology research–advantages and current limitations. Toxicol Pathol 2003;31(Suppl):62-87
   PubMedGoogle Scholar
• Lammer E, Carr GJ, Wendler K, Is the fish embryo toxicity test (FET) with the zebrafish (Danio rerio) a potential alternative for the fish acute toxicity test? Comp Biochem Physiol C Toxicol Pharmacol 2009;149:196-209
   PubMed Web of Science ®Google Scholar
• Peterson RT, Link BA, Dowling JE, Schreiber SL. Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc Natl Acad Sci USA 2000;97:12965-9
   PubMed Web of Science ®Google Scholar
• Langheinrich U. Zebrafish: a new model on the pharmaceutical catwalk. Bioessays 2003;25:904-12
   PubMed Web of Science ®Google Scholar
• Zon LI, Peterson RT. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 2005;4:35-44
   PubMed Web of Science ®Google Scholar
• Parng C. In vivo zebrafish assays for toxicity testing. Curr Opin Drug Discov Devel 2005;8:100-6
   PubMed Web of Science ®Google Scholar
• Eimon PM, Rubinstein AL. The use of in vivo zebrafish assays in drug toxicity screening. Expert Opin Drug Metab Toxicol 2009;5:393-401
   PubMed Web of Science ®Google Scholar
• Rubinstein AL. Zebrafish assays for drug toxicity screening. Expert Opin Drug Metab Toxicol 2006;2:231-40
   PubMed Web of Science ®Google Scholar
• Redfern WS, Waldron G, Winter MJ, Zebrafish assays as early safety pharmacology screens: paradigm shift or red herring? J Pharmacol Toxicol Methods 2008;58:110-17
   PubMedGoogle Scholar
• McGrath P, Li CQ. Zebrafish: a predictive model for assessing drug-induced toxicity. Drug Discov Today 2008;13:394-401
   PubMed Web of Science ®Google Scholar
• Belanger SE, Balon EK, Rawlings JM. Saltatory ontogeny of fishes and sensitive early life stages for ecotoxicology tests. Aquat Toxicol 2010;97:88-95
   PubMed Web of Science ®Google Scholar
• Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection animal used in scientific purposes. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2010:276:0033:0079:EN:PDF [Last accessed 25 January 2011]
   Google Scholar
• Kimmel CB, Ballard WW, Kimmel SR, Stages of embryonic development of the zebrafish. Dev Dyn 1995;203:253-310
   PubMed Web of Science ®Google Scholar
• Parichy DM, Elizondo MR, Mills MG, Normal table of postembryonic zebrafish development: staging by externally visible anatomy of the living fish. Dev Dyn 2009;238:2975-3015
   PubMed Web of Science ®Google Scholar
• Yang L, Ho NY, Alshut R, Zebrafish embryos as models for embryotoxic and teratological effects of chemicals. Reprod Toxicol 2009;28:245-53
   PubMed Web of Science ®Google Scholar
• Parng C, Seng WL, Semino C, McGrath P. Zebrafish: a preclinical model for drug screening. Assay Drug Dev Technol 2002;1:41-8
   PubMed Web of Science ®Google Scholar
• Hill AJ, Teraoka H, Heideman W, Peterson RE. Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 2005;86:6-19
   PubMed Web of Science ®Google Scholar
• Lam SH, Mathavan S, Tong Y, Zebrafish whole-adult-organism chemogenomics for large-scale predictive and discovery chemical biology. PLoS Genet 2008;4:e1000121
   PubMed Web of Science ®Google Scholar
• Alderton W, Berghmans S, Butler P, Accumulation and metabolism of drugs and CYP probe substrates in zebrafish larvae. Xenobiotica 2010;40:547-57
   PubMed Web of Science ®Google Scholar
• Jones HS, Panter GH, Hutchinson TH, Chipman JK. Oxidative and conjugative xenobiotic metabolism in zebrafish larvae in vivo. Zebrafish 2010;7:23-30
   PubMed Web of Science ®Google Scholar
• Scornaienchi ML, Thornton C, Willett KL, Functional differences in the cytochrome P450 1 family enzymes from zebrafish (Danio rerio) using heterologously expressed proteins. Arch Biochem Biophys 2010;502:17-22
   PubMed Web of Science ®Google Scholar
• Kurogi K, Dillon J, Nasser A, Sulfation of drug compounds by the zebrafish cytosolic Sulfotransferases (SULTs). Drug Metab Lett 2010;4:62-8
   PubMedGoogle Scholar
• Liu TA, Bhuiyan S, Liu MY, Zebrafish as a model for the study of the phase II cytosolic sulfotransferases. Curr Drug Metab 2010;11:538-46
   Google Scholar
• Gehrig J, Reischl M, Kalmar E, Automated high-throughput mapping of promoter-enhancer interactions in zebrafish embryos. Nat Methods 2009;6:911-16
   PubMed Web of Science ®Google Scholar
• Pardo-Martin C, Chang TY, Koo BK, High-throughput in vivo vertebrate screening. Nat Methods 2010;7:634-6
   PubMed Web of Science ®Google Scholar
• Vogt A, Codore H, Day BW, Development of automated imaging and analysis for zebrafish chemical screens. J Vis Exp 2010;(40):1900. Available from: http://www.jove.com/details.stp?id=1900 doi: 10.3791/1900
   PubMedGoogle Scholar
• Augustine-Rauch K, Zhang CX, Panzica-Kelly JM. In vitro developmental toxicology assays: a review of the state of the science of rodent and zebrafish whole embryo culture and embryonic stem cell assays. Birth Defects Res C Embryo Today 2010;90:87-98
   PubMed Web of Science ®Google Scholar
• Strahle U, Grabher C. The zebrafish embryo as a model for assessing off-target drug effects. Dis Model Mech 2010;3:689-92
   PubMed Web of Science ®Google Scholar
• ZFIN: The Zebrafish Model Organism Database. Available from: http://zfin.org/cgi-bin/webdriver?MIval=aa-ZDB_home.apg [Last accessed 25 January 2011]
   Google Scholar
• Sukardi H, Ung CY, Gong Z, Lam SH. Incorporating zebrafish omics into chemical biology and toxicology. Zebrafish 2010;7:41-52
   PubMed Web of Science ®Google Scholar
• Yang L, Kemadjou JR, Zinsmeister C, Transcriptional profiling reveals barcode-like toxicogenomic responses in the zebrafish embryo. Genome Biol 2007;8:R227
   PubMed Web of Science ®Google Scholar
• Kokel D, Bryan J, Laggner C, Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol 2010;6:231-7
   PubMed Web of Science ®Google Scholar
• Mohideen MA, Beckwith LG, Tsao-Wu GS, Histology-based screen for zebrafish mutants with abnormal cell differentiation. Dev Dyn 2003;228:414-23
   PubMed Web of Science ®Google Scholar
• Sabaliauskas NA, Foutz CA, Mest JR, High-throughput zebrafish histology. Methods 2006;39:246-54
   PubMed Web of Science ®Google Scholar
• Sachidanandan C, Yeh JR, Peterson QP, Peterson RT. Identification of a novel retinoid by small molecule screening with zebrafish embryos. PLoS One 2008;3:e1947
   PubMed Web of Science ®Google Scholar
• Brannen KC, Panzica-Kelly JM, Danberry TL, Augustine-Rauch KA. Development of a zebrafish embryo teratogenicity assay and quantitative prediction model. Birth Defects Res B Dev Reprod Toxicol 2010;89:66-77
   PubMed Web of Science ®Google Scholar
• Panzica-Kelly JM, Zhang CX, Danberry TL, Morphological score assignment guidelines for the dechorionated zebrafish teratogenicity assay. Birth Defects Res B Dev Reprod Toxicol 2010;89:382-95
   PubMed Web of Science ®Google Scholar
• Chapin R, Augustine-Rauch K, Beyer B, State of the art in developmental toxicity screening methods and a way forward: a meeting report addressing embryonic stem cells, whole embryo culture, and zebrafish. Birth Defects Res B Dev Reprod Toxicol 2008;83:446-56
   PubMed Web of Science ®Google Scholar
• Trepakova ES, Koerner J, Pettit SD, A HESI consortium approach to assess the human predictive value of non-clinical repolarization assays. J Pharmacol Toxicol Methods 2009;60:45-50
   PubMedGoogle Scholar
• Langheinrich U, Vacun G, Wagner T. Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia. Toxicol Appl Pharmacol 2003;193:370-82
   PubMed Web of Science ®Google Scholar
• Milan DJ, Peterson TA, Ruskin JN, Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 2003;107:1355-8
   PubMed Web of Science ®Google Scholar
• Burns CG, Milan DJ, Grande EJ, High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat Chem Biol 2005;1:263-4
   PubMed Web of Science ®Google Scholar
• Mittelstadt SW, Hemenway CL, Craig MP, Hove JR. Evaluation of zebrafish embryos as a model for assessing inhibition of hERG. J Pharmacol Toxicol Methods 2008;57:100-5
   PubMedGoogle Scholar
• Berghmans S, Butler P, Goldsmith P, Zebrafish based assays for the assessment of cardiac, visual and gut function–potential safety screens for early drug discovery. J Pharmacol Toxicol Methods 2008;58:59-68
   PubMedGoogle Scholar
• Kuryshev YA, Ficker E, Wang L, Pentamidine-induced long QT syndrome and block of hERG trafficking. J Pharmacol Exp Ther 2005;312:316-23
   PubMed Web of Science ®Google Scholar
• Tsutsui H, Higashijima S, Miyawaki A, Okamura Y. Visualizing voltage dynamics in zebrafish heart. J Physiol 2010;588:2017-21
   PubMed Web of Science ®Google Scholar
• Chan PK, Lin CC, Cheng SH. Noninvasive technique for measurement of heartbeat regularity in zebrafish (Danio rerio) embryos. BMC Biotechnol 2009;9:11
   PubMedGoogle Scholar
• Coffin AB, Ou H, Owens KN, Chemical screening for hair cell loss and protection in the zebrafish lateral line. Zebrafish 2010;7:3-11
   PubMed Web of Science ®Google Scholar
• Ou HC, Santos F, Raible DW, Drug screening for hearing loss: using the zebrafish lateral line to screen for drugs that prevent and cause hearing loss. Drug Discov Today 2010;15:265-71
   PubMed Web of Science ®Google Scholar
• Chiu LL, Cunningham LL, Raible DW, Using the zebrafish lateral line to screen for ototoxicity. J Assoc Res Otolaryngol 2008;9:178-90
   PubMed Web of Science ®Google Scholar
• Owens KN, Coffin AB, Hong LS, Response of mechanosensory hair cells of the zebrafish lateral line to aminoglycosides reveals distinct cell death pathways. Hear Res 2009;253:32-41
   PubMed Web of Science ®Google Scholar
• Ou HC, Raible DW, Rubel EW. Cisplatin-induced hair cell loss in zebrafish (Danio rerio) lateral line. Hear Res 2007;233:46-53
   PubMed Web of Science ®Google Scholar
• Selderslaghs IW, Hooyberghs J, De Coen W, Locomotor activity in zebrafish embryos: a new method to assess developmental neurotoxicity. Neurotoxicol Teratol 2010;32:460-71
   PubMed Web of Science ®Google Scholar
• Irons TD, MacPhail RC, Hunter DL, Padilla S. Acute neuroactive drug exposures alter locomotor activity in larval zebrafish. Neurotoxicol Teratol 2010;32:84-90
   PubMed Web of Science ®Google Scholar
• Rihel J, Prober DA, Arvanites A, Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 2010;327:348-51
   PubMed Web of Science ®Google Scholar
• Webb KJ, Norton WH, Trumbach D, Zebrafish reward mutants reveal novel transcripts mediating the behavioral effects of amphetamine. Genome Biol 2009;10:R81
   PubMedGoogle Scholar
• Chen J, Carney SA, Peterson RE, Heideman W. Comparative genomics identifies genes mediating cardiotoxicity in the embryonic zebrafish heart. Physiol Genomics 2008;33:148-58
   PubMed Web of Science ®Google Scholar
• Fan CY, Cowden J, Simmons SO, Gene expression changes in developing zebrafish as potential markers for rapid developmental neurotoxicity screening. Neurotoxicol Teratol 2010;32:91-8
   PubMed Web of Science ®Google Scholar
• Kleinow KM, Nicols JW, Hayton WL, Toxicokinetics in Fishes. In: Di Giulio RT, Hinton DE, editors, The Toxicology of Fishes. CRC Press; 2008. p. 55-152
   Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001;46:3-26
   PubMed Web of Science ®Google Scholar
• Williams DP, Kitteringham NR, Naisbitt DJ, Are chemically reactive metabolites responsible for adverse reactions to drugs? Curr Drug Metab 2002;3:351-66
   PubMedGoogle Scholar
• Endres CJ, Hsiao P, Chung FS, Unadkat JD. The role of transporters in drug interactions. Eur J Pharm Sci 2006;27:501-17
   PubMed Web of Science ®Google Scholar
• Dean M, Annilo T. Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. Annu Rev Genomics Hum Genet 2005;6:123-42
   PubMed Web of Science ®Google Scholar
• Scholz S, Fischer S, Gundel U, The zebrafish embryo model in environmental risk assessment–applications beyond acute toxicity testing. Environ Sci Pollut Res Int 2008;15:394-404
   PubMed Web of Science ®Google Scholar
• Ou HC, Cunningham LL, Francis SP, Identification of FDA-approved drugs and bioactives that protect hair cells in the zebrafish (Danio rerio) lateral line and mouse (Mus musculus) utricle. J Assoc Res Otolaryngol 2009;10:191-203
   PubMed Web of Science ®Google Scholar
• Augustine-Rauch K. Generation and Preliminary Assessment of a Zebrafish Teratogenicity Assay: an overview of how BMS generated the assay. Bristol-Myers Squibb. Available from: http://www.hesiglobal.org/files/public/Committees/DART/Meetings%20and%20Workshops/AlternativeAssayWkshp_Augustine.pdf [Last accessed 17 November 2010]
   Google Scholar